Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 7
Review
Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,291 | Dovepress* | 11,291+ | 1,023 | 12,314 | |
Totals | 11,291 | 1,023 | 12,314 | ||
*Since 19 July 2017 |
View citations on Google Scholar